Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Endogenous Metabolite
    (2)
  • Serine Protease
    (2)
  • Thrombin
    (2)
  • PAI-1
    (1)
  • Others
    (8)
TargetMol | Tags By ResearchField
  • Immune System
    (2)
  • Inflammation
    (2)
Filter
Search Result
Results for "

human plasmin

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    9
    TargetMol | All_Pathways
  • Recombinant Protein
    3
    TargetMol | Recombinant_Protein
  • Cell Research
    2
    TargetMol | Cell_Research_Reagents
  • ZK824859
    T134092271122-53-1
    ZK824859 is an orally available and selective inhibitor of urokinase plasminogen activator (uPA) with IC50 values of 79 nM for human uPA, 1580 nM for tPA, and 1330 nM for plasmin.
    • $2,370
    10-14 weeks
    Size
    QTY
  • ZK824859 hydrochloride (2271122-53-1 free base)
    ZK824859 hydrochloride
    T13409L
    ZK824859 hydrochloride is an oral available and selective inhibitor of urokinase plasminogen activator (uPA)(IC50s of 79 nM, 1580 nM and 1330 nM for human uPA, tPA, and plasmin, respectively).
    • $1,820
    10-14 weeks
    Size
    QTY
  • JTV-803 mesylate
    JTV-803, JTV803, JTV 803
    T27698247131-79-9
    JTV-803 is a factor Xa inhibitor. JTV-803 showed a competitive inhibitory effect on human factor Xa, with a K(i) value of 0.019 microM and IC(50) value of 0.081 microM. JTV-803 was 100 times more selective in inhibiting human factor Xa as compared to its
    • $2,120
    8-10 weeks
    Size
    QTY
  • SSR-182289A (Free)
    SSR-182289A, SSR182289A, SSR-182289, SSR182289, SSR 182289A, SSR 182289
    T28857363151-21-7
    SSR-182289A (Free) is a thrombin inhibitor.
    • Inquiry Price
    3-6 months
    Size
    QTY
  • PKSI-527
    T35579128837-71-8
    PKSI-527 is a non-covalent, highly selective small molecule inhibitor of plasma kallikrein with an inhibition constant (Ki) of 0.81 µM for plasma kallikrein. PKSI-527 modulates the kallikrein-kinin system by inhibiting bradykinin generation, significantly reduces arthritis severity in a collagen-induced arthritis mouse model, and improves indicators of disseminated intravascular coagulation and organ damage in endotoxin-induced rat models.
    • $78
    5 days
    Size
    QTY
  • N-p-Tosyl-Gly-Pro-Lys-pNA (acetate)
    T3622588793-79-7
    N-p-Tosyl-Gly-Pro-Lys-pNA is a colorimetric substrate for plasmin.1,2,3Plasmin binds and hydrolyzes N-p-tosyl-Gly-Pro-Lys-pNA to releasep-nitroanilide (pNA), which can be quantified by colorimetric detection at 405 nm as a measure of plasmin activity. 1.Jespersen, J., Gram, J., and Astrup, T.The autodigestion of human plasmin follows a bimolecular mode of reaction subject to product inhibitionThromb. Res.41(3)395-404(1986) 2.Kim, S.H., and Choi, N.S.Electrophoretic analysis of protease inhibitors in fibrin zymographyAnal. Biochem.270(1)179-181(1999) 3.Chen, T., and Rael, E.D.Purification of M5, a fibrinolytic proteinase from Crotalus molossus molossus venom that attacks complementInt. J. Biochem. Cell Biol.29(5)789-799(1997)
    • $123
    35 days
    Size
    QTY
  • p-APMSF (hydrochloride)
    T3701974938-88-8
    p-APMSF is an irreversible inhibitor of serine proteases with Ki values of 1.02, 1.18, 1.5, and 1.54 μM for bovine trypsin, human thrombin, bovine plasmin, and bovine Factor Xa, respectively. It is selective for these proteases over bovine chymotrypsin and acetylcholinesterase.
    • $120
    35 days
    Size
    QTY
  • Human Factor XIIIa
    TRP-00477
    Human Factor XIIIa, a transglutaminase, catalyzes protein cross-linking to stabilize blood clots. It helps protect clots from plasmin degradation, playing a critical role in maintaining hemostasis and preventing excessive bleeding.
    • Inquiry Price
    Inquiry
    Size
    QTY
  • Streptokinase, Streptococcus hemolyticus
    TRP-00915
    Streptokinase, an enzyme from Streptococcus hemolyticus (EC 3.4.99.0), is secreted by various streptococci. It binds to and activates human plasminogen. The complex formed between streptokinase and human plasminogen can activate additional unbound plasminogen by cleaving specific bonds, resulting in the production of plasmin.
    • Inquiry Price
    Inquiry
    Size
    QTY